Non-atheroprotective effects of statins: a systematic review

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Abhimanyu BeriSnigdha B Mahajan

Abstract

Since the introduction of HMG-CoA reductase inhibitors (statins) for lowering lipids, a large amount of data has been published demonstrating their potential benefits in conditions as varied as cancer, osteoporosis, and Alzheimer's dementia. We reviewed the published literature on MEDLINE from articles between 1950 and 2008 on the non-atheroprotective effects of statins and noted consistent benefits of statin use in improving outcomes of ventricular arrhythmias, sudden cardiac death, cardiac transplant rejection, chronic obstructive pulmonary disease, and sepsis. However, for these conditions, the level of evidence was inadequate to recommend statin use. The evidence for improving outcomes in atrial fibrillation, mortality in heart failure, contrast-induced nephropathy, cataract, age-related macular degeneration, sub-arachnoid hemorrhage, osteoporosis, dementia, and cancer incidence was conflicting and inconclusive. Furthermore, we found that most of the literature consists of small observational studies and their conclusions are often not corroborated by results from larger or randomized studies. Pending large, well designed, randomized trials, we conclude that there is no definite evidence for the use of statins in any condit...Continue Reading

References

Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Dec 15, 1996·The American Journal of Cardiology·G H JenkinsD R Singer
May 12, 2000·The American Journal of Medicine·M F MuldoonS B Manuck
Jun 24, 2000·JAMA : the Journal of the American Medical Association·P S WangJ Avorn
Nov 23, 2000·Lancet·H JickD A Drachman
Apr 20, 2001·JAMA : the Journal of the American Medical Association·T P van StaaC Cooper
May 12, 2001·Clinical Orthopaedics and Related Research·J W Pritchett
Aug 3, 2001·Archives of Internal Medicine·J G RayA Laupacis
Jun 14, 2001·The American Journal of Medicine·L M Bjerre, J LeLorier
Aug 10, 2001·JAMA : the Journal of the American Medical Association·C R MeierH Jick
Sep 26, 2001·Archives of Internal Medicine·R G SchliengerC R Meier
Mar 5, 2002·Archives of Internal Medicine·Julie A PascoUNKNOWN Geelong Osteoporosis Study
Mar 7, 2002·Diabetes Research and Clinical Practice·Kaushik SenRavindra Mohan Pandey
Mar 14, 2002·Archives of Neurology·Kristine YaffeDeborah Grady
Jun 27, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Ihab HajjarG Paul Eleazer
Nov 13, 2002·Journal of the American College of Cardiology·Mandeep R MehraCarl J Lavie
Mar 5, 2003·American Journal of Respiratory and Critical Care Medicine·Bruce A JohnsonSteven R Duncan
Aug 9, 2003·Chest·Yaniv Almog
Aug 13, 2003·Archives of Ophthalmology·Ronald KleinKaren J Cruickshanks
Aug 23, 2003·Journal of the American College of Cardiology·Yinong Young-XuCharles M Blatt
Dec 17, 2003·The American Journal of Cardiology·Yinong Young-XuShmuel Ravid
Dec 17, 2003·The American Journal of Cardiology·Francesco Antonini-CanterinGian Luigi Nicolosi
Feb 21, 2004·Journal of the American College of Cardiology·Tamara B HorwichGregg C Fonarow
Mar 17, 2004·The American Journal of Cardiology·Arnljot TveitLars Gullestad
Apr 3, 2004·American Journal of Ophthalmology·Amod GuptaAnil Bhansali
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Anna SimonJoost P H Drenth
May 18, 2004·Lancet·Timothy VollmerInderjit Singh
Jun 16, 2004·Archives of Ophthalmology·Gerald McGwinPaul P Lee
Jun 19, 2004·BMJ : British Medical Journal·David AtkinsUNKNOWN GRADE Working Group
Aug 4, 2004·Circulation·Yaniv AlmogAbraham Danon
Oct 20, 2004·Circulation·Folkert W AsselbergsUNKNOWN Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators
Nov 9, 2004·Atherosclerosis. Supplements·Akira Endo
Dec 14, 2004·The American Journal of Medicine·Matthew F MuldoonStephen B Manuck
Jan 12, 2005·Archives of Internal Medicine·Joel G RayJack V Tu
Jan 27, 2005·The American Journal of Cardiology·Audrey H WuKevin D O'Brien
Feb 9, 2005·Archives of General Psychiatry·Peter P ZandiUNKNOWN Cache County Study investigators

❮ Previous
Next ❯

Citations

Nov 16, 2011·European Journal of Clinical Pharmacology·Chun Shing KwokYoon Kong Loke
Mar 21, 2013·F1000prime Reports·May Km Leung, Michael G Irwin
Jan 11, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yijia ZhangRichard A Reinhardt
Jan 11, 2011·Expert Opinion on Therapeutic Patents·Jeffrey A Pfefferkorn
Sep 21, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yaa-Hui DongMei-Shu Lai
Mar 16, 2011·European Journal of Internal Medicine·I KouroumichakisE Maltezos
Jan 10, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Steven C GreenwayYuk Law
Jun 6, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Matthew BaumgartHarry Johns
Feb 12, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Olivia FromiguePierre J Marie
Jan 28, 2014·International Journal of Clinical Practice·A S Wierzbicki, R Louis
Jun 2, 2017·World Journal of Orthopedics·Candice L DowneyEleftherios Tsiridis
May 4, 2011·Current Opinion in Cardiology·Umar Sadat
Jan 1, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Mario Marzilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Circulation
Richard C PasternakNational Heart, Lung and Blood Institute
The Journal of Antimicrobial Chemotherapy
S Jerwood, J Cohen
Kidney International
Luis Miguel Blanco-ColioJesús Egido
Current Drug Targets. Cardiovascular & Haematological Disorders
Claire ArnaudFrançois Mach
© 2022 Meta ULC. All rights reserved